FR2494693B1 - - Google Patents

Info

Publication number
FR2494693B1
FR2494693B1 FR8024717A FR8024717A FR2494693B1 FR 2494693 B1 FR2494693 B1 FR 2494693B1 FR 8024717 A FR8024717 A FR 8024717A FR 8024717 A FR8024717 A FR 8024717A FR 2494693 B1 FR2494693 B1 FR 2494693B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8024717A
Other versions
FR2494693A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR8024717A priority Critical patent/FR2494693A1/fr
Priority to DE19813143179 priority patent/DE3143179A1/de
Priority to GR66585A priority patent/GR78026B/el
Priority to MX10163181U priority patent/MX6424E/es
Priority to LU83775A priority patent/LU83775A1/fr
Priority to CH7460/81A priority patent/CH649549A5/fr
Priority to PT74019A priority patent/PT74019B/fr
Priority to IL64328A priority patent/IL64328A/xx
Priority to NO813945A priority patent/NO813945L/no
Priority to NZ199008A priority patent/NZ199008A/en
Priority to GB8135005A priority patent/GB2087889B/en
Priority to CA000390531A priority patent/CA1162544A/fr
Priority to SE8106918A priority patent/SE8106918L/xx
Priority to IT25212/81A priority patent/IT1195292B/it
Priority to IE2722/81A priority patent/IE52160B1/en
Priority to ES507317A priority patent/ES507317A0/es
Priority to AU77700/81A priority patent/AU546924B2/en
Priority to DK515681A priority patent/DK515681A/da
Priority to BE0/206615A priority patent/BE891204A/fr
Priority to JP56187652A priority patent/JPS57116070A/ja
Priority to ZA818082A priority patent/ZA818082B/xx
Priority to AT0501381A priority patent/AT379594B/de
Priority to NL8105282A priority patent/NL8105282A/nl
Publication of FR2494693A1 publication Critical patent/FR2494693A1/fr
Application granted granted Critical
Publication of FR2494693B1 publication Critical patent/FR2494693B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Secondary Cells (AREA)
  • Electrolytic Production Of Metals (AREA)
  • Carbon And Carbon Compounds (AREA)
  • X-Ray Techniques (AREA)
FR8024717A 1980-11-21 1980-11-21 Derives de l'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de)(naphtyridine-1,5), leur preparation et leur application en therapeutique Granted FR2494693A1 (fr)

Priority Applications (23)

Application Number Priority Date Filing Date Title
FR8024717A FR2494693A1 (fr) 1980-11-21 1980-11-21 Derives de l'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de)(naphtyridine-1,5), leur preparation et leur application en therapeutique
DE19813143179 DE3143179A1 (de) 1980-11-21 1981-10-30 Naphthyridinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
GR66585A GR78026B (fr) 1980-11-21 1981-11-17
MX10163181U MX6424E (es) 1980-11-21 1981-11-18 Procedimiento para preparar derivados de la hexahidro 2,3,3a,4,5,6,-1h-indol(3,2,1-de)(naftiridina-1,5)
LU83775A LU83775A1 (fr) 1980-11-21 1981-11-19 Derives de naphtyridine,leur preparation et leur application en therapeutique
AU77700/81A AU546924B2 (en) 1980-11-21 1981-11-20 Indolo(3,2,1-de)(1,5-naphthyridines)
IL64328A IL64328A (en) 1980-11-21 1981-11-20 2,3,3a,4,5,6-hexahydro-1h-indolo(3,2,1-de)(1,5-naphthyridine)derivatives,their preparation and pharmaceutical compositions containing them
NO813945A NO813945L (no) 1980-11-21 1981-11-20 Fremgangsmaate for fremstilling av naftyridinderivater
NZ199008A NZ199008A (en) 1980-11-21 1981-11-20 2,3,3a,4,5,6-hexahydro-ih-indolo(3,2,1-de)(1,5)-naphthyridines
GB8135005A GB2087889B (en) 1980-11-21 1981-11-20 Naphthyridine derivatives
CA000390531A CA1162544A (fr) 1980-11-21 1981-11-20 Derives de naphthyridine
SE8106918A SE8106918L (sv) 1980-11-21 1981-11-20 Naftyridinderivat
CH7460/81A CH649549A5 (fr) 1980-11-21 1981-11-20 Derives de naphtyridine, leur preparation et medicaments les contenant.
IE2722/81A IE52160B1 (en) 1980-11-21 1981-11-20 Naphthyridine derivatives
ES507317A ES507317A0 (es) 1980-11-21 1981-11-20 Procedimiento para la preparacion de derivados de la hexahi-dro-2,3,3,4,5.6-1h-indol(3,2,1-de)(naftiridina-1,5)
PT74019A PT74019B (fr) 1980-11-21 1981-11-20 Procede de preparation de derives de naphtyridine et de compositions pharmaceutiques qui les contiennent
DK515681A DK515681A (da) 1980-11-21 1981-11-20 Fremgangsmaade til fremstilling af naphtyridinderivater
BE0/206615A BE891204A (fr) 1980-11-21 1981-11-20 Derives de naphtyridine, leur preparation et leur application en therapeutique
JP56187652A JPS57116070A (en) 1980-11-21 1981-11-20 Naphthiridine derivatives and application to medicine
ZA818082A ZA818082B (en) 1980-11-21 1981-11-20 Naphthyridine derivatives
AT0501381A AT379594B (de) 1980-11-21 1981-11-20 Verfahren zur herstellung von neuen 2,3,3a,4,5,6hexahydro-1h-indolo(3,2,1-de)-(1,5-naphtyridin) -derivaten und ihre pharmazeutisch zulaessigen saeureadditionssalze
IT25212/81A IT1195292B (it) 1980-11-21 1981-11-20 Derivati della naftiridina,loro preparazione e loro impiego in terapeutica
NL8105282A NL8105282A (nl) 1980-11-21 1981-11-23 Naftyridinederivaten, de bereiding van deze derivaten en de therapeutische toepassing hiervan.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8024717A FR2494693A1 (fr) 1980-11-21 1980-11-21 Derives de l'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de)(naphtyridine-1,5), leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2494693A1 FR2494693A1 (fr) 1982-05-28
FR2494693B1 true FR2494693B1 (fr) 1983-03-04

Family

ID=9248208

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8024717A Granted FR2494693A1 (fr) 1980-11-21 1980-11-21 Derives de l'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de)(naphtyridine-1,5), leur preparation et leur application en therapeutique

Country Status (22)

Country Link
JP (1) JPS57116070A (fr)
AT (1) AT379594B (fr)
AU (1) AU546924B2 (fr)
BE (1) BE891204A (fr)
CA (1) CA1162544A (fr)
CH (1) CH649549A5 (fr)
DE (1) DE3143179A1 (fr)
DK (1) DK515681A (fr)
ES (1) ES507317A0 (fr)
FR (1) FR2494693A1 (fr)
GB (1) GB2087889B (fr)
GR (1) GR78026B (fr)
IE (1) IE52160B1 (fr)
IL (1) IL64328A (fr)
IT (1) IT1195292B (fr)
LU (1) LU83775A1 (fr)
NL (1) NL8105282A (fr)
NO (1) NO813945L (fr)
NZ (1) NZ199008A (fr)
PT (1) PT74019B (fr)
SE (1) SE8106918L (fr)
ZA (1) ZA818082B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2527210A1 (fr) * 1982-05-18 1983-11-25 Synthelabo Enantiomeres d'hexahydro-2,3,3a,4,5,6 1h-indolo(3,2,1-de) (naphtyridine-1,5), leur procede de separation et leur application en therapeutique
EP0357417A1 (fr) * 1988-09-01 1990-03-07 Glaxo Group Limited Dérivés de lactames
CN113214250B (zh) * 2021-04-28 2022-06-14 华南理工大学 一种稠合六氢-1,6-萘啶类化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD129791A5 (de) * 1976-04-13 1978-02-08 Synthelabo Verfahren zur herstellung von naphtyridinderivaten
GB1550496A (en) * 1976-12-31 1979-08-15 Logeais Labor Jacques 1,2,3,3a4,5-hexahydro-canthine derivatives a process for their preparation and their therapeutic applications

Also Published As

Publication number Publication date
IE812722L (en) 1982-05-21
AU546924B2 (en) 1985-09-26
DE3143179A1 (de) 1982-06-24
IL64328A (en) 1985-02-28
AT379594B (de) 1986-01-27
IT8125212A0 (it) 1981-11-20
CH649549A5 (fr) 1985-05-31
PT74019B (fr) 1983-12-07
IT1195292B (it) 1988-10-12
ES8207176A1 (es) 1982-09-01
CA1162544A (fr) 1984-02-21
GR78026B (fr) 1984-09-26
ES507317A0 (es) 1982-09-01
NO813945L (no) 1982-05-24
DK515681A (da) 1982-05-22
IE52160B1 (en) 1987-07-22
JPS57116070A (en) 1982-07-19
ZA818082B (en) 1982-10-27
PT74019A (fr) 1981-12-01
FR2494693A1 (fr) 1982-05-28
NL8105282A (nl) 1982-06-16
IL64328A0 (en) 1982-02-28
BE891204A (fr) 1982-05-21
SE8106918L (sv) 1982-05-22
AU7770081A (en) 1982-05-27
NZ199008A (en) 1984-07-31
GB2087889A (en) 1982-06-03
ATA501381A (de) 1985-06-15
GB2087889B (en) 1984-01-25
LU83775A1 (fr) 1983-09-01

Similar Documents

Publication Publication Date Title
FR2473046B1 (fr)
FR2476382B1 (fr)
FR2475366B1 (fr)
FR2472954B1 (fr)
FR2473311B1 (fr)
JPS5739241U (fr)
FR2473491B3 (fr)
FR2473859B1 (fr)
FR2473157B3 (fr)
FR2473449B1 (fr)
DE3153278A1 (fr)
FR2476227B1 (fr)
FR2476426B1 (fr)
FR2475767B1 (fr)
FR2476178B1 (fr)
FR2474900B1 (fr)
FR2474994B3 (fr)
FR2474736B1 (fr)
FR2494693B1 (fr)
FR2475810B1 (fr)
FR2473839B1 (fr)
FR2475286B1 (fr)
FR2475657B1 (fr)
FR2476433B3 (fr)
FR2474745B1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse